ADARx Pharmaceuticals Insider Trades
NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 13 · $87.75M
- Sales
- 0 · $0
- Shares bought / sold
- 5.16M / 0
- Net activity
- Net buying $87.7 million
ADARx Pharmaceuticals insider activity
Over the last 12 months, ADARx Pharmaceuticals insiders reported 51 transactions on SEC Form 4: 13 open-market purchases and 0 sales. Insiders bought $87.7 million and sold $0 worth of stock, for net insider buying of $87.7 million. The most recent filing shows Chimovits Erez (Director) reporting a transaction in 7,127,019 shares on Sep 28, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ADRX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ADRX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% Owner | Conversion | 307,738 | — | Form 4 |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% Owner | Conversion | 307,738 | — | Form 4 |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% Owner | Conversion | 153,868 | — | Form 4 |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% Owner | Conversion | 513,067 | — | Form 4 |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% Owner | Conversion | 1,667,469 | — | Form 4 |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% Owner | Conversion | 8,908,775 | — | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Buy | 592,593 | $10.07M | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Conversion | 169,001 | — | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Conversion | 1,667,468 | — | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Buy | 414,814 | $7.05M | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Conversion | 1,538,691 | — | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Buy | 592,593 | $10.07M | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Conversion | 512,897 | — | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Conversion | 1,113,666 | — | Form 4 |
| Sep 28, 2026 | George SimeonDirector | Conversion | 3,334,938 | — | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Buy | 592,593 | $10.07M | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 169,001 | — | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 1,667,468 | — | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Buy | 414,814 | $7.05M | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 1,538,691 | — | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Buy | 592,593 | $10.07M | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 512,897 | — | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 1,113,666 | — | Form 4 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC10% Owner | Conversion | 3,334,938 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Buy | 588,235 | $10.00M | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Buy | 61,516 | $1.05M | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 256,448 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 513,067 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 1,333,975 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 7,127,019 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Buy | 300,249 | $5.10M | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 564,187 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 769,601 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 2,000,962 | — | Form 4 |
| Sep 28, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirector | Conversion | 10,690,530 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Buy | 588,235 | $10.00M | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Buy | 61,516 | $1.05M | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 256,448 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 513,067 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 1,333,975 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 7,127,019 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Buy | 300,249 | $5.10M | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 564,187 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 769,601 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 2,000,962 | — | Form 4 |
| Sep 28, 2026 | GORDON CARL LDirector | Conversion | 10,690,530 | — | Form 4 |
| Sep 28, 2026 | Chimovits ErezDirector | Buy | 61,516 | $1.05M | Form 4 |
| Sep 28, 2026 | Chimovits ErezDirector | Conversion | 256,448 | — | Form 4 |
| Sep 28, 2026 | Chimovits ErezDirector | Conversion | 513,067 | — | Form 4 |
| Sep 28, 2026 | Chimovits ErezDirector | Conversion | 1,333,975 | — | Form 4 |
| Sep 28, 2026 | Chimovits ErezDirector | Conversion | 7,127,019 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4